Patents not only protect valuable technology, they are increasingly becoming assets in their own right, traded and licensed in a standalone market. WIPR looks at Intellectual Ventures and RPX Corporation to find out more about NPEs.
Companies have always invested in research and development and filed for patents to protect those investments, but now more than ever they are going on the offensive. If one company cannot out-sell a competitor, it may try to out-litigate it.
A competitive edge is not the only reason to litigate a patent. There are companies that do not manufacture or otherwise produce anything in the industries where their patents are normally used.
‘Non-practising entity’ (NPE) is often used to describe companies like Intellectual Ventures, Acacia Research, Millennium Partners and Round Rock Research LLC because they assert patents and agree licensing deals for patents without, as far as anyone can see, manufacturing, producing or selling products covered by those patents. What’s more, this makes them difficult to countersue.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email tech support.
NPEs, Intellectual Ventures, RPX Corporation